Logivir 800mg Tablet DT

Uses of Logivir 800mg Tablet DT

Logivir 800mg Tablet DT is used for the treatment or prevention of the following disease(s):

Chickenpox, Herpes Simplex, Herpes Zoster

Side effects of Logivir 800mg Tablet DT

The most common side effects of Logivir 800mg Tablet DT are - Nausea, Vomiting, Diarrhea, Decreased Appetite, Dizziness, Headache, Tiredness

These side effects can usually occur in patients. However, these are only indicative and not all patients will experience them.

Precautions while using Logivir 800mg Tablet DT

Do not use Logivir 800mg Tablet DT if you are allergic to - Acyclovir

If you have heart disease, liver or kidney disease, drug or alcohol addiction, consult your doctor before using Logivir 800mg Tablet DT.

If you are allergic to any medicine or food, consult your doctor before using this medicine.

Use this medicine under the supervision of your doctor.

To avoid an adverse reaction, consult your doctor if you are already taking other medicines.

How Logivir 800mg Tablet DT works

Logivir 800mg Tablet DT contains - Acyclovir

Acyclovir converts to acyclovir triphosphate, becoming part of DNA chain.

Dosage of Logivir 800mg Tablet DT

The dosage of Logivir 800mg Tablet DT depends on many factors such as the patient age, health, medical condition or history of the patient and many other conditions.

Please use this medicine as prescribed by your doctor.

Overdose of Logivir 800mg Tablet DT

If you forget to take a dose of Logivir 800mg Tablet DT, do not take two doses at the same time, there is a risk of overdose.

If you notice any unusual reaction in your body after taking this medicine, contact your doctor immediately or call your local medical emergency number.

Precautions & Warnings

• 

• Alcohol Information will be added soon.

• 

• Pregnancy Information will be added soon.

• 

• Breastfeeding Information will be added soon.

• 

• Driving Information will be added soon.

• 

• Kidney Information will be added soon.

• 

• Liver Information will be added soon.